FFS
ABBV icon

Flavin Financial Services’s AbbVie ABBV Stock Holding History

Flavin Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$428K Buy
1,968
+108
+6% +$24K 0.29% 60
2025
Q4 		$425K Sell
1,860
-100
-5% -$22.8K 0.29% 59
2025
Q3 		$454K Hold
1,960
– – 0.32% 57
2025
Q2 		$364K Hold
1,960
– – 0.35% 59
2025
Q1 		$411K Hold
1,960
– – 0.38% 58
2024
Q4 		$348K Buy
+1,960
New +$360K 0.33% 59

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flavin Financial Services's ABBV Position: Q1 2026 in Review

Flavin Financial Services increased its AbbVie (ABBV) stake by 5.8% in Q1 2026, buying an estimated $24K and bringing the position to 1,968 shares worth $428K. The position accounts for 0.29% of the portfolio, ranked #60.

Flavin Financial Services first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $454K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Flavin Financial Services held 1,968 shares of AbbVie worth $428K as of Q1 2026.
  • Flavin Financial Services bought 108 AbbVie shares in Q1 2026, an estimated $24K.
  • AbbVie made up 0.29% of Flavin Financial Services's portfolio in Q1 2026, its #60 holding.
  • Flavin Financial Services first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Flavin Financial Services's AbbVie position peaked at $454K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Flavin Financial Services's 13F filing for Q1 2026, filed 7 May 2026.